Holen Sie sich die Stockscreener-App
12.48
1.96%
-0.25
Handel nachbörslich:
12.46
-0.02
-0.16%
Schlusskurs vom Vortag:
$12.73
Offen:
$12.74
24-Stunden-Volumen:
2.28M
Relative Volume:
0.85
Marktkapitalisierung:
$983.29M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-13.57
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
+4.17%
1M Leistung:
+27.22%
6M Leistung:
-0.16%
1J Leistung:
+54.07%
1-Tages-Spanne:
$12.46
$13.02
1-Wochen-Bereich:
$12.00
$13.02
52-Wochen-Spanne:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Firmenname
CorMedix Inc
Sektor
Branche
Telefon
908-517-9500
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Vergleichen Sie CRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
12.48 | 1.00B | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-13 | Eingeleitet | D. Boral Capital | Buy |
| 2024-08-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-02-17 | Eingeleitet | Needham | Buy |
| 2020-09-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-09-21 | Eingeleitet | Truist | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2018-12-06 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-08-10 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-05-05 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-11-11 | Bestätigt | FBR & Co. | Outperform |
| 2016-03-17 | Bestätigt | FBR Capital | Outperform |
| 2016-03-03 | Eingeleitet | FBR Capital | Outperform |
| 2015-11-16 | Bestätigt | ROTH Capital | Neutral |
| 2015-10-29 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Bestätigt | ROTH Capital | Buy |
| 2011-10-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Finviz
Ocugen Stock Surges 75% Year to Date: What's in Store for 2026? - Finviz
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? - Yahoo Finance
Responsive Playbooks and the CRMD Inflection - Stock Traders Daily
Meme Stocks: Is Adyen NV 1N8 stock attractive post correctionEarnings Recap Report & Safe Capital Allocation Plans - moha.gov.vn
CorMedix (CRMD): Assessing Valuation After a Strong Multi‑Year Share Price Run - Yahoo Finance
Why CorMedix could be the biopharma name to watch early in 2026 - MSN
CorMedix Builds a Real Revenue Story as DefenCath Adoption Accelerates - Investing.com
CorMedix Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Why CorMedix Could be the Biopharma Name to Watch Early in 2026 - sharewise.com
CorMedix Inc.'s (NASDAQ:CRMD) 28% Jump Shows Its Popularity With Investors - simplywall.st
CorMedix CEO Todisco sells $360,000 in CRMD stock - Investing.com India
CorMedix CEO Todisco sells $360,000 in CRMD stock By Investing.com - Investing.com Nigeria
CRMD SEC FilingsCormedix 10-K, 10-Q, 8-K Forms - Stock Titan
How CorMedix Inc. stock compares to market leadersWeekly Profit Summary & Fast Moving Stock Trade Plans - Улправда
Can CorMedix Inc. stock surprise with earnings upside2025 Growth vs Value & Weekly Breakout Watchlists - moha.gov.vn
Bear Alert: How CorMedix Inc. stock compares to market leadersMarket Growth Summary & Free Technical Confirmation Trade Alerts - Улправда
How rising interest rates impact CorMedix Inc. stockGDP Growth & Real-Time Sentiment Analysis - Улправда
How CorMedix Inc. stock reacts to global recession fears2025 Winners & Losers & Short-Term Swing Trade Alerts - Улправда
CEO Todisco Sells 30,000 ($360K) Of CorMedix Inc [CRMD] - TradingView — Track All Markets
Income Plays: Can CorMedix Inc. stock surprise with earnings upsideWeekly Trade Review & Accurate Intraday Trading Signals - Улправда
Will CorMedix Inc. (19KA) stock benefit from infrastructure billJuly 2025 Pullbacks & Low Risk Investment Opportunities - Улправда
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? - Yahoo Finance
Will CorMedix Inc. (19KA) stock gain from lower interest rates2025 Historical Comparison & Fast Exit/Entry Strategy Plans - DonanımHaber
Sentiment Recap: Will CorMedix Inc. (19KA) stock gain from lower interest ratesJuly 2025 Retail & Safe Entry Point Identification - DonanımHaber
Is CorMedix Inc. stock a top pick in earnings season2025 Market Outlook & Smart Investment Allocation Insights - DonanımHaber
Will CorMedix Inc. (19KA) stock hit analyst forecastsWeekly Trade Review & Weekly High Potential Stock Alerts - DonanımHaber
Can CorMedix Inc. (19KA) stock surprise with quarterly resultsQuarterly Market Summary & AI Powered Buy/Sell Recommendations - ulpravda.ru
Breakout Move: How sustainable is CorMedix Inc. stock dividend payoutWeekly Stock Analysis & Risk Controlled Stock Alerts - Улправда
CorMedix announces interim results for DefenCath - TipRanks
Why Is CorMedix Stock Rising Today? - Asianet Newsable
CorMedix Says Interim DefenCath Study Data Show Fewer Infections - marketscreener.com
Cormedix reports positive data from real world study of Defencath - marketscreener.com
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath - The Manila Times
CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? - Yahoo Finance
(CRMD) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN
CRMD up more than 40% YTD: Time to buy, sell or hold the stock? - MSN
Cormedix Director Makes a Significant Stock Sale! - TipRanks
CorMedix Q3 2025 Earnings Preview - MSN
CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? - sharewise.com
CorMedix director Dillione sells $408,000 in stock By Investing.com - Investing.com South Africa
CorMedix director Dillione sells $408,000 in stock - Investing.com
Steven Lefkowitz Implements A Sell Strategy: Offloads $475K In Cormedix Stock - Benzinga
CorMedix Inc. Stock (CRMD) Opinions on Insider Selling and Growth Metrics - Quiver Quantitative
CorMedix Insider Sold Shares Worth $408,000, According to a Recent SEC Filing - marketscreener.com
CorMedix Director Janet Dillione Sells 34,000 Shares - TradingView — Track All Markets
Dir Dillione Sells 34,000 ($408K) Of CorMedix Inc [CRMD] - TradingView — Track All Markets
Lefkowitz Steven W, director at CorMedix, sells $475k in CRMD stock By Investing.com - Investing.com South Africa
Lefkowitz Steven W, director at CorMedix, sells $475k in CRMD stock - Investing.com Nigeria
Finanzdaten der CorMedix Inc-Aktie (CRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):